Why is Neuronetics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -5.26% of over the last 5 years
2
With a growth in Net Sales of 7.75%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -12.79 MM
- NET SALES(HY) At USD 76.23 MM has Grown at 39.96%
- NET PROFIT(HY) Higher at USD -17.41 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -64.43%, its profits have fallen by -0.9%
4
High Institutional Holdings at 92.26%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.02% over the previous quarter.
5
Below par performance in long term as well as near term
- Along with generating -64.43% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Neuronetics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuronetics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Neuronetics, Inc.
-64.43%
-0.38
104.38%
S&P 500
22.24%
1.67
13.28%
Quality key factors
Factor
Value
Sales Growth (5y)
24.82%
EBIT Growth (5y)
-5.26%
EBIT to Interest (avg)
-6.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.10
Sales to Capital Employed (avg)
1.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
92.26%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.99
EV to EBIT
-4.02
EV to EBITDA
-4.52
EV to Capital Employed
2.13
EV to Sales
0.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.93%
ROE (Latest)
-174.88%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -12.79 MM
NET SALES(HY)
At USD 76.23 MM has Grown at 39.96%
NET PROFIT(HY)
Higher at USD -17.41 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 18.63 times
DEBTORS TURNOVER RATIO(HY)
Highest at 7.04 times
-1What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 498.81 %
Here's what is working for Neuronetics, Inc.
Net Sales
At USD 76.23 MM has Grown at 39.96%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD -17.41 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -12.79 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 18.63 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 7.04 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Neuronetics, Inc.
Debt-Equity Ratio
Highest at 498.81 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






